SLS international is a language services company which offers translations globally. The Company offers a range of services, including multilingual translations into all Spanish variants, localization, adaptation and content editing. It uses the mother-tongue linguists in order to meet the demanding standards. Its professional team includes translators, terminologists, linguistic engineers, IT experts, technical editors and graphic designers. The Company’s production offices and management departments are located in Argentina, Spain, Uruguay and Panama. The Company offers translations within a range of fields such as legal, financial, business, economy, and health sciences, marketing, advertising and technical. It translates and adapts all of the customer’s software products, such as resource files, online help, printed documentation, including compilation and testing of various components.
Industry, Sector and Symbol
Stock Exchange AMEX
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolAMEX:SLS
Previous Symbol
CUSIPN/A
Phone+1-417-8834549
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable
SLS International (AMEX:SLS) Frequently Asked Questions
What is SLS International's stock symbol?
SLS International trades on the AMEX under the ticker symbol "SLS."
How were SLS International's earnings last quarter?
SLS International Inc (AMEX:SLS) posted its quarterly earnings data on Thursday, November, 15th. The biotechnology company reported ($0.53) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.17. View SLS International's Earnings History.
What price target have analysts set for SLS?
5 brokerages have issued 12 month price targets for SLS International's shares. Their forecasts range from $4.00 to $13.00. On average, they anticipate SLS International's share price to reach $7.3333 in the next twelve months. This suggests a possible upside of 916,566.7% from the stock's current price. View Analyst Price Targets for SLS International.
What is the consensus analysts' recommendation for SLS International?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SLS International in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for SLS International.
What are Wall Street analysts saying about SLS International stock?
Here are some recent quotes from research analysts about SLS International stock:
- 1. Maxim Group analysts commented, "Sellas announced final data from the triple negative breast cancer (TNBC) group in the P2b study of nelipepimut-S vaccine (NPS, NeuVax) combined with Herceptin. The data vs. Herceptin alone, continue to demonstrate improved reduction in risk of recurrence or death, and improved disease free survival (DFS), this time at median followup of over 2 years (19 mo at interim in April)." (10/22/2018)
- 2. According to Zacks Investment Research, "SELLAS Life Sciences Group is a development-stage biopharmaceutical company. It focused on novel cancer immunotherapeutics for cancer indications. The company's product candidate, galinpepimut-S, is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 protein, which is present in an array of tumor types. SELLAS Life Sciences Group Inc., formerly known as Galena Biopharma Inc., is based in NEW YORK, United States. " (8/3/2018)
Has SLS International been receiving favorable news coverage?
Media headlines about SLS stock have been trending positive this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SLS International earned a daily sentiment score of 2.2 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future.
Are investors shorting SLS International?
SLS International saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 2,086,731 shares, an increase of 93.3% from the October 15th total of 1,079,328 shares. Based on an average trading volume of 3,685,819 shares, the days-to-cover ratio is currently 0.6 days. Currently, 11.9% of the shares of the company are short sold. View SLS International's Current Options Chain.
Who are SLS International's key executives?
SLS International's management team includes the folowing people:
- Angelos M. Stergiou M.D., President, Chief Executive Officer, Director
- Aleksey N. Krylov, Interim Chief Financial Officer, Treasurer
- Nicholas J. Sarlis M.D. Ph.D., Chief Medical Officer, Senior Vice President
- Gregory M. Torre Ph.D. J.D., Chief Regulatory Officer, Senior Vice President
- John Thomas Burns, Vice President - Finance, Corporate Controller
- Fabio Lopez, Director
- David A. Scheinberg, Director
- Stephen F. Ghiglieri, Independent Director (Age 55)
- Robert L. Van Nostrand, Independent Director
- John Varian, Independent Director
How do I buy shares of SLS International?
Shares of SLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is SLS International's stock price today?
One share of SLS stock can currently be purchased for approximately $0.0008.
What is SLS International's official website?
How can I contact SLS International?
SLS International's mailing address is 3119 S Scenic Ave, SPRINGFIELD, MO 65807-3926, United States. The biotechnology company can be reached via phone at +1-417-8834549 or via email at [email protected]
MarketBeat Community Rating for SLS International (AMEX SLS)
MarketBeat's community ratings are surveys of what our community members think about SLS International and other stocks. Vote "Outperform" if you believe SLS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLS will underperform the S&P 500 over the long term. You may vote once every thirty days.
